María de Ujué Moreno

Dr. María de Ujué Moreno

1. Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona, Spain
+2
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
BLBegoña López
Begoña López
SRSusana Ravassa
Susana Ravassa
MMMaría de Ujué Moreno
María de Ujué Moreno
GJGorka San José
Gorka San José
JBJavier Beaumont
Javier Beaumont
JDJavier Díez
Javier Díez

13 August 2013 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
SRSabrina H Rossi
Sabrina H Rossi
EMEmily P McQuarrie
Emily P McQuarrie
WMWilliam H Miller
William H Miller
RMRuth M Mackenzie
Ruth M Mackenzie
JDJane A Dymott
Jane A Dymott
CDChristian Delles
Christian Delles
Background: Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status. Methods: We studied 160 patients with CAD and 169 subjects without CAD. The 4-variable MDRD formula was used to estimate glomerular filtration rate (eGFR); impaired renal function was defined as eGFR <60 mL/min. Carotid-femoral pulse wave velocity (PWV) was measured with the SphygmoCor® device. Circulating biomarkers were assessed in plasma using xMAP® multiplexing technology. Results: Patients with CAD and impaired renal function had greater PWV compared to those with CAD and normal renal function (10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s; P < 0.001). In all patients, PWV was a function of eGFR (β = −0.293; P < 0.001) even after adjustment for age, sex, systolic blood pressure, body mass index and presence or absence of CAD. Patients with CAD and impaired renal function had higher levels of adhesion and inflammatory molecules including E-selectin and osteopontin (all P < 0.05) compared to those with CAD alone, but had similar levels of markers of oxidative stress. Conclusions: Renal function is a determinant of vascular stiffness even in patients with severe atherosclerotic disease. This was paralleled by differences in markers of cell adhesion and inflammation. Increased vascular stiffness may therefore be linked to inflammatory remodeling of the vasculature in people with impaired renal function, irrespective of concomitant atherosclerotic disease.

22 May 2013 in Clinical Science
Verified
Journal Article
Closed access
PDF file
MMMaría de Ujué Moreno
María de Ujué Moreno
IGIdoia Gallego
Idoia Gallego
BLBegoña López
Begoña López
AGArantxa González
Arantxa González
AFAna Fortuño
Ana Fortuño
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba
The NADPH oxidases are a key family of ROS (reactive oxygen species)-producing enzymes which may differentially contribute to cardiac pathophysiology. Animal studies show uncertain results regarding the regulation of cardiac Nox4 by pressure overload and no data are available on human myocardial Nox4. In the present study, we evaluated Nox4 expression and its relationship with myocardial remodelling and LV (left ventricular) function in patients with severe AS (aortic valve stenosis). Endomyocardial biopsies from 34 patients with AS were obtained during aortic valve replacement surgery. LV morphology and function were assessed by echocardiography. Myocardial samples from subjects deceased of non-CVDs (cardiovascular diseases) were analysed as controls. Nox4 localization was evaluated by immunohistochemistry and quantified by Western blot. Myocardial capillary density, fibrosis and cardiomyocyte dimensions and apoptosis were assessed histologically to evaluate myocardial remodelling. Nox4 was present in samples from all subjects and expressed in cardiomyocytes, VSMCs (vascular smooth muscle cells), endothelium and fibroblasts. Nox4 levels were reduced 5-fold in AS patients compared with controls (P<0.01). Nox4 levels directly correlated with cardiomyocyte cross-sectional area (r=0.299, P<0.05) and diameter (r=0.406, P<0.05) and capillary density (r=0.389, P<0.05), and inversely with cardiomyocyte apoptosis (r=−0.316, P<0.05) in AS patients. In addition, Nox4 levels correlated with echocardiographic parameters (LV ejection fraction: r=0.353, P<0.05; midwall fractional shortening: r=0.355, P<0.05; deceleration time: r=−0.345, P<0.05) in AS patients. Nox4 is expressed in human myocardium and reduced in AS patients. The observed associations of Nox4 with cardiomyocyte parameters and capillary density in AS patients suggest a potential role of Nox4 deficiency in the myocardial remodelling present in the human pressure-overloaded heart.

3 August 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba
MMMaría de Ujué Moreno
María de Ujué Moreno
Reactive oxygen species (ROS), both as second messengers and as contributors to oxidative stress, play a major, complex role in the initiation, development and outcomes of cardiovascular diseases

1 January 2010 in Drug News & Perspectives
Verified
Journal Article
Closed access
MMMaría de Ujué Moreno
María de Ujué Moreno
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba
Oxidative stress plays a key role in the pathophysiology of coronary artery disease, and constitutes a common mechanism behind the risk factors associated with this disease such as atherosclerosis, hypertension, diabetes and the metabolic syndrome. Oxidative stress is defined as an imbalance between the production of reactive oxygen and nitrogen species and the detoxification by the appropriate cellular systems. Reactive oxygen species induce cardiovascular dysfunction by modulating cell contraction/dilation, migration, growth/apoptosis and extracellular matrix protein turnover, which contribute to vascular and cardiac remodeling. In the last decade, the NADPH oxidase family has emerged as one of the most relevant sources of reactive oxygen species within the cardiovascular system. Recent data suggest a significant role of the genetic background in NADPH oxidase regulation. Common genetic polymorphisms within the promoter and exonic sequences of CYBA, the gene that encodes the p22phox subunit of the NADPH oxidase, have been characterized in the context of cardiovascular diseases. This review aims to present the current state of research into these polymorphisms with regards to their relationship to coronary artery disease.

5 January 2004 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
ACAnna Cabré
Anna Cabré
JGJosefa Girona-Tell
Josefa Girona-Tell
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba
MMMaría de Ujué Moreno
María de Ujué Moreno
JDJavier Díez
Javier Díez
LMLluís Masana
Lluís Masana
Studies that characterize transcriptional regulatory elements involve the site-directed mutagenesis methodology to generate deletions, insertions and point mutations. Commercial PCR-based system kits are widely used to introduce up to four base changes in a target sequence. Sequential mutagenesis experiments allow more than four bases to be altered. In this work, we show that the QuikChange site-directed mutagenesis kit developed by Stratagene, with an optimum primer design, can change eight adjacent bases. This approach allows us to study the effect of DNA sequence changes on functionality of specific sequences from gene target regions, including promoters, exons and introns. As a result of this methodology, a faster and cheaper way of introducing this number of mutations is achieved in a single step with only one pair of primers, thus reducing the possibility of potential random mutation in the rest of the target sequence.